Cidofovir topical gel: Began a Phase I/II trial in Canada to determine safety and tolerance as well as antiviral action of different concentrations. Patients wi

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: Cidofovir topical gel ( GS 504) Indication: Recurrent herpes simplex virus in immunocompetent patients Status: Began a Phase I/II trial in Can...